CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (5,068,200)	$ (36,572,200)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,000	28,900
Amortization of discounts on convertible and promissory notes	0	564,800
Change in warrant liability	0	1,894,700
Stock-based compensation	306,700	3,769,900
Expense related to modification of warrants, including exchange of warrants for Series C Preferred and common stock	57,400	122,300
Amortization of deferred rent	(18,100)	(11,600)
Fair value of common stock granted for services	217,000	500,000
Fair value of Series B Preferred stock granted for services	375,000	707,500
Fair value of warrants granted for services and interest	227,500	0
Foreign currency transaction loss	0	(6,300)
Loss on extinguishment of debt	0	26,700,200
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	40,400	24,200
Accounts payable and accrued expenses, including accrued interest	(36,800)	(51,900)
Net cash used in operating activities	(3,873,100)	(2,329,500)
Cash flows from investing activities:
Purchases of equipment	(7,700)	0
Net cash used in investing activities	(7,700)	0
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units	9,537,100	280,000
Net proceeds from issuance of Series B Preferred Units	278,000	2,722,800
Repayment of capital lease obligations	(500)	(500)
Repayment of notes	(105,200)	(48,800)
Net cash provided by financing activities	9,709,400	2,953,500
Net increase in cash and cash equivalents	5,828,600	624,000
Cash and cash equivalents at beginning of period	428,500	70,000
Cash and cash equivalents at end of period	6,257,100	694,000
Supplemental disclosure of noncash activites:
Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred	0	18,891,400
Insurance premiums settled by issuing note payable	117,500	79,400
Accrued dividends on Series B Preferred	780,800	828,000
Accrued dividends on Series B Preferred settled upon conversion by issuance of common stock	$ 1,768,800	$ 22,700